Januvia 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FJRWT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,345
Award facts
- Contract value 100% obligated
- $2,344.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,344.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Januvia 50 mg tablets (90-count units). The delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, operates under a firm fixed-price arrangement with no set-aside designation, allowing the contractor to compete on an unrestricted basis. This award reflects DMS Pharmaceutical Group's continued participation in the Defense Logistics Agency's Medical Supply Chain division procurement activities, demonstrating the company's competitive capability in federal pharmaceutical distribution.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. This contract positions DMS Pharmaceutical Group as a critical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy, enabling the company to fulfill specialized pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FJRWT?
SPE2DB26FJRWT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FJRWT worth?
The government has obligated $2,345 on SPE2DB26FJRWT.
Is contract SPE2DB26FJRWT an order under another contract?
Yes. SPE2DB26FJRWT is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWT competed?
The extent of competition for SPE2DB26FJRWT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award